Whole-cell vaccination provides multiple known and unknown TAAs to activate CD4+ T helper and CD8+ cytotoxic lymphocytes (CTL) simultaneously via the vast amount of uncharacterized and characterized T cell epitopes, decreasing the chance of tumor immune escape. This evidence concerns the gene CD8A and neoplasm.